Výsledky vyhledávání - "Nasir H. Naqvi"

Neural correlates of drinking reduction during cognitive behavioral therapy for alcohol use disorder

Autor: Nasir H. Naqvi, A. Benjamin Srivastava, Juan Sanchez-Peña, Jessica Lee, John J. Mariani, Gaurav H. Patel, Frances R. Levin

Publikováno v: bioRxiv

Cognitive behavioral therapy (CBT) is an effective treatment for alcohol use disorder (AUD). We hypothesized that the dorsolateral prefrontal cortex (DLPFC), a brain region implicated in cognitive control and goal-directed behavior, plays a role beha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824eaf32540ab61ab53850b50793fadb
https://europepmc.org/articles/PMC9934652/

Zobrazit plný text záznamu

Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users

Autor: John J. Mariani, Nasir H. Naqvi, Amy L. Mahony, Frances R. Levin, Sean X. Luo, Muhammad N Iqbal

Publikováno v: Am J Addict

Background and objectives Highly potent synthetic opioids (HPSO) are increasingly responsible for opioid overdose deaths in the United States. Methods In an open-label, uncontrolled trial to test the feasibility of extended-release buprenorphine (BXR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55861eb251c922531489877bada13f94
https://doi.org/10.1111/ajad.13018

Zobrazit plný text záznamu

Plný text ve formátu HTML

Drinking reduction during cognitive behavioral therapy for alcohol use disorder is associated with reduction in anterior insula-bed nucleus of the stria terminalis resting state functional connectivity

Autor: A Benjamin Srivastava, Juan Sanchez-Peña, John J. Mariani, Frances R. Levin, Gaurav H. Patel, Nasir H. Naqvi

Publikováno v: Alcohol Clin Exp Res

Background Connectivity between the anterior insula (AI) and the bed nucleus of the stria terminalis (BNST) may play a role in negative emotions that drive compulsive drinking in patients with alcohol use disorder (AUD). We hypothesized that reductio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720a5789bfb99cba1b0e4c0c4b57801c
https://europepmc.org/articles/PMC8429084/

Zobrazit plný text záznamu

Open Label Trial of a Single Day Induction onto Buprenorphine Extended-Release Injection for Users of Heroin and Fentanyl

Autor: Frances R. Levin, John J. Mariani, Amy L. Mahony, Samuel C Podell, Nasir H. Naqvi, Daniel J. Brooks, Sean X. Luo, Christina A. Brezing

Publikováno v: Am J Addict

Background and objectives Fentanyl and other highly potent synthetic opioids are the leading cause of opioid overdose deaths in the United States. Methods This study was an open-label, uncontrolled 12-week outpatient clinical trial to test the feasib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f979c9efa35adbdbfdc2f4356ff2fadd
https://europepmc.org/articles/PMC8459386/

Zobrazit plný text záznamu

An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorder

Autor: Amy L. Mahony, Sean X. Luo, Martina Pavlicova, John J. Mariani, Daniel J. Brooks, Frances R. Levin, Nasir H. Naqvi, C. Jean Choi, Christina A. Brezing, Zora Kosoff

Publikováno v: The American journal of drug and alcohol abuse. 47(4)

Background: There is a need for alcohol use disorder (AUD) pharmacotherapy that can be administered to actively drinking outpatients. Pregabalin, a gabapentoid anticonvulsant, has preliminary evide...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74373a47175118dfaf1cafe85828497
https://pubmed.ncbi.nlm.nih.gov/34092158

Zobrazit plný text záznamu

Plný text ve formátu HTML

Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial

Autor: Adam Bisaga, Cale Basaraba, Martina Pavlicova, Daniel J. Brooks, Amy L. Mahony, Frances R. Levin, C. Jean Choi, John J. Mariani, Nasir H. Naqvi

Publikováno v: Drug Alcohol Depend

Background Opioid Use Disorder (OUD) is a significant public health problem associated with severe morbidity and mortality. While effective pharmacotherapies are available, limitations exist with each. Induction onto extended-release naltrexone (XR-N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8afa66df0b9076fd22ddbbb56b81469
https://pubmed.ncbi.nlm.nih.gov/33418204

Zobrazit plný text záznamu

Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users

Autor: Kenneth M. Carpenter, Frances R. Levin, Nasir H. Naqvi, John J. Mariani, Edward V. Nunes, Amy L. Mahony, C. Jean Choi, Elias Dakwar, Adam Bisaga, Kyle M. Kampman, Martina Pavlicova, Daniel J. Brooks

Publikováno v: Drug Alcohol Depend

BACKGROUND: Cocaine use disorder (CUD) remains a substantial public health problem with no clearly effective pharmacotherapy available. In a prior trial, combined amphetamine and topiramate treatment significantly reduced cocaine use among individual

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7530ad90cccdafb8fc1fadde6c880fe4
https://pubmed.ncbi.nlm.nih.gov/31753736

Zobrazit plný text záznamu

Quetiapine treatment for cannabis use disorder

Autor: C. Jean Choi, Kenneth M. Carpenter, Frances R. Levin, John J. Mariani, Nasir H. Naqvi, Edward V. Nunes, Amy L. Mahony, Martina Pavlicova, Daniel J. Brooks, Adam Bisaga, Cale Basaraba

Publikováno v: Drug and Alcohol Dependence. 218:108366

Backround Pharmacotherapy for cannabis use disorder (CUD) is an important unmet public health need. Methods In a 12-week randomized double-blind placebo-controlled trial, the efficacy of quetiapine (300 mg nightly) for the treatment of CUD was tested

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f852f88011a3045b48678d0d66e2222a
https://doi.org/10.1016/j.drugalcdep.2020.108366

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání